Bausch Health Companies Stock (NYSE: BHC)

Bausch Health Companies

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health Cos

Alibaba's Philosophy

News

Intraday Update

Markets

Movers

Trading Ideas

BABA

FTAI

SHAK

Alibaba, Hasbro, Shake Shack, Bausch Health And Other Big Stocks Moving Higher On Thursday

Bridgewater,,Nj,,Usa,-,August,23,,2022:,Bausch,Health,Us

Earnings

After-Hours Center

Bausch Health Companies reported its fourth-quarter results after Wednesday&#39;s closing bell. Here&#39;s a look at the details from the report:

Bausch Health Shares Climb On Better-Than-Expected Q4 Revenue, Strong Forward Guidance

Tesla Inc.

Pre-Market Outlook

ANNA

BTDR

CIFR

CURV

IBRX

KRNT

LION

NVDA

TSLA

Tesla, Nvidia, GM And Other Big Stocks Moving Lower In Monday&#39;s Pre-Market Session

Bausch Health Companies Inc. Common Stock

Bausch Health Companies Inc

BillionHappiness

BENCHMARK HLDGS PLC by Benchmark Hldgs PLC

Benchmark Holdings PLC

Press Releases

PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS

Bausch Health Appoints New Chief Medical Officer and Head of R&D

Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day

Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb

Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program

Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025

Bausch Health Provides Update on Strategic Alternatives

Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program

Events

Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference

Comments

Bausch Health Companies

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga